Biotage
197.2 SEK +1.28%Be the first to follow this company
Biotage is active in biotechnology. The company provides solutions in chromatography, organic synthesis, and sample preparation. The company has operations on a global level, mainly concentrated in Europe, North America, and Asia, and a large part of the projects are also conducted in collaboration with other players in the said market. Customers are found in health and care, as well as in the food industry.
Revenue
-
EBIT %
-
P/E
59.04
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BIOT
Daily low / high price
193.8 / 198.1
SEK
Market cap
15.91B SEK
Turnover
11.7M SEK
Volume
59K
Latest videos
Financial calendar
Interim report
23.10.2024
Annual report
19.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gamma Biosciences | 16.9 % | 17.0 % |
SEB Fonder | 7.6 % | 7.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Change in number of votes
Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan
Biotage AB (publ) Interim report January-June 2024
![Biotage, Audiocast with teleconference, Q1'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/229414cf-594e-4ddc-8ce3-b52cefe59730.png)
Biotage, Audiocast with teleconference, Q1'24
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2024
Biotage AB (publ) Interim report January-March 2024
Biotage AB (publ) publishes its 2023 Annual Report and Corporate Governance Report
NOTICE OF ANNUAL GENERAL MEETING OF BIOTAGE AB (PUBL)
![Biotage, Audiocast with teleconference, Q4'23](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/dc1b6808-9d54-4eb3-aea7-4f79eeec5e9c.png)
Biotage, Audiocast with teleconference, Q4'23
Biotage AB (publ) publishes new Financial Goals
Biotage appoints Andrew Kellett as CFO
Biotage AB (publ) Year end Report January - December 2023
Biotage CEO & President steps down from his role
![Biotage, Audiocast with teleconference, Q3'23](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/19a65cc6-c622-4aad-bab7-1fb70a31b5c7.png)